Compounds > rosiglitazone

Page last updated: 2024-08-25

rosiglitazone and tzd 18

rosiglitazone has been researched along with tzd 18 in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, JP; Bergman, JP; Desai, RC; Doebber, TW; Gratale, DF; Han, W; Heck, JV; Leung, K; MacNaul, KL; Metzger, EJ; Moller, DE; Sahoo, SP	1
Berger, JP; Desai, RC; Doebber, TW; Franklin, R; Gratale, DF; Han, W; Heck, JV; Koyama, H; Leung, K; Lombardo, VK; MacNaul, KL; Metzger, E; Moller, DE; Sahoo, SP	1
Henke, BR	1
Ahmad Noruddin, NA; Al-Najjar, BO; Shu-Chien, AC; Taha, MO; Tengku Muhammad, TS; Wahab, HA	1

Reviews

1 review(s) available for rosiglitazone and tzd 18

Article	Year
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes. Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17 Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors	2004

Other Studies

3 other study(ies) available for rosiglitazone and tzd 18

Article	Year
5-aryl thiazolidine-2,4-diones: discovery of PPAR dual alpha/gamma agonists as antidiabetic agents. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Administration, Oral; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones; Transcription Factors	2003
Aryloxazolidinediones: identification of potent orally active PPAR dual alpha/gamma agonists. Bioorganic & medicinal chemistry letters, 2003, Oct-20, Volume: 13, Issue:20 Topics: Administration, Oral; Hypoglycemic Agents; Oxazoles; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Transcription Factors	2003
Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling. European journal of medicinal chemistry, 2011, Volume: 46, Issue:6 Topics: Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Hep G2 Cells; Humans; Ligands; Models, Molecular; Molecular Structure; PPAR gamma; Quantitative Structure-Activity Relationship; ROC Curve; Stereoisomerism	2011